Austar Lifesciences : Announcements and Notices – Poll results of the Annual General Meeting

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

POLL RESULTS OF THE ANNUAL GENERAL MEETING

The Board is pleased to announce that at the Annual General Meeting held on 23 June 2017, all proposed resolutions as set out in the notice of the Annual General Meeting dated 25 April 2017 were duly passed by the Shareholders by way of poll.

Reference is made to the circular of Austar Lifesciences Limited ("Company") dated 25 April 2017 ("Circular") in relation to, among other matters, the proposals for the (i) grant of general mandates to issue and repurchase shares of the Company; and (ii) re-election of the retiring directors of the Company. Unless otherwise specified, capitalised terms used in this announcement shall have the same meanings as those defined in the Circular.

POLL RESULTS OF THE ANNUAL GENERAL MEETING

The Board is pleased to announce that at the Annual General Meeting held on 23 June 2017, all proposed resolutions as set out in the notice of the Annual General Meeting dated 25 April 2017 ("Notice") were duly passed by the Shareholders by way of poll.

As at the date of the Annual General Meeting, there were a total of 512,582,000 Shares in issue. To the best of the Directors' knowledge, information and belief having made all reasonable enquiries, no Shareholder was required to abstain from voting on the resolutions proposed at the Annual General Meeting. As such, there were a total of 512,582,000 Shares, representing 100% of the issued share capital of the Company as at the date of the Annual General Meeting, entitling Shareholders to attend and vote on the resolutions proposed at the Annual General Meeting. None of the Shareholders was entitled to attend and abstain from voting in favour of the resolutions proposed at the Annual General Meeting according to Rule

13.40 of the Listing Rules. None of the Shareholders has stated their intention in the Circular to vote against the resolutions proposed or to abstain from voting at the Annual General Meeting.

The full text of the resolutions was set out in the Notice. The poll results are as follows:

ORDINARY RESOLUTIONS			Number of votes and percentage
			For	Against
1	To receive and approve the audited consolidated financial statements and the reports of the Directors and the Company's auditors for the year ended 31 December 2016		368,832,000 (100.00%)	0 (0.00%)
2	(a)	To re-elect Mr. Ho Kwok Keung, Mars as a Director	368,832,000 (100.00%)	0 (0.00%)
	(b)	To re-elect Mr. Ho Kin Hung as a Director	368,832,000 (100.00%)	0 (0.00%)
	(c)	To re-elect Mr. Chen Yuewu as a Director	368,832,000 (100.00%)	0 (0.00%)
	(d)	To authorise the Board to fix the remuneration of Directors	368,832,000 (100.00%)	0 (0.00%)
3	To re-appoint PricewaterhouseCoopers as auditors of the Company and authorise the Board to fix their remuneration		368,832,000 (100.00%)	0 (0.00%)
4(A)	To grant a general mandate to the Directors to allot, issue and otherwise deal with the Company's shares		368,832,000 (100.00%)	0 (0.00%)
4(B)	To grant a general mandate to the Directors to repurchase the Company's shares		368,832,000 (100.00%)	0 (0.00%)
4(C)	To add the number of the Company's shares repurchased by the Company to the mandate granted to the Directors under resolution numbered 4(A)		368,832,000 (100.00%)	0 (0.00%)

Note: The number of votes and percentage of the voting as stated above are based on the total number of Shares held by the Shareholders who attended and voted at the Annual General Meeting in person, by authorised corporate representative or by proxy.

As all of the votes were cast in favour of each of the resolutions proposed at the Annual General Meeting, each of the resolutions was duly passed by the Shareholders as an ordinary resolution of the Company.

The Company's branch share registrar and transfer office in Hong Kong, Tricor Investor Services Limited, acted as the scrutineer for the vote-taking at the Annual General Meeting.

On behalf of the Board Austar Lifesciences Limited Ho Kwok Keung, Mars

Chairman and Chief Executive Officer

Hong Kong, 23 June 2017

As at the date of this announcement, the Board comprises four executive Directors, namely Mr. Ho Kwok Keung, Mars, Mr. Ho Kin Hung, Mr. Chen Yuewu and Madam Zhou Ning; one non-executive Director, namely Madam Ji Lingling; and three independent non-executive Directors, namely Mr. Cheung Lap Kei, Madam Chiu Hoi Shan and Mr. Raco Ivan Jordanov (alias Racho Jordanov).